New pill aims to keep lung cancer from coming back after surgery
NCT ID NCT06352008
Summary
This study is testing if a capsule drug called anlotinib can help prevent lung cancer from returning in patients who have had surgery. It is for people with non-small cell lung cancer who still had cancer cells present after their initial treatment. The main goal is to see if the drug can extend the time patients live without their cancer coming back or getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University Cancer Institute & Hospital
RECRUITINGTianjin, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.